Loading financials from SEC filings…
Specialty industrial machinery · Industrials · Fiscal year ends Aug 31
Enerpac Tool reported revenue of $652M in the fiscal year ended Aug 2026, up 5.7% from the year before. Operating income was $129M, an operating margin of 19.8%, and net income was $90M. Operating cash flow of $130M less capital expenditure of $11M left free cash flow of $120M. Net debt was $8M.
Ranks among the 34 specialty industrial machinery companies we cover (1st = best; for debt, the least indebted). Green = top third, red = bottom third.
Last 5 fiscal years
| Fiscal year | Aug 2022 | Aug 2023 | Aug 2024 | Aug 2025 | Aug 2026 |
|---|---|---|---|---|---|
| Revenue | 571 | 598 | 590 | 617 | 652 |
| Cost of revenue | 306 | 303 | 289 | 305 | 331 |
| Gross profit | 265 | 295 | 301 | 312 | 321 |
| Research & development | 7.3 | 9.0 | 12.4 | 14.5 | 15.4 |
| Selling, general & admin | 217 | 205 | 169 | 167 | 182 |
| Operating income | 30.7 | 83.9 | 122 | 134 | 129 |
| Pre-tax income | 24.0 | 68.9 | 106 | 121 | 118 |
| Income tax | 4.4 | 15.2 | 23.3 | 28.0 | 27.8 |
| Net income | 15.7 | 46.6 | 85.7 | 92.7 | 89.7 |
| Diluted EPS | 0.26 | 0.82 | 1.56 | 1.70 | 1.72 |
| Diluted shares | 59.9 | 57.1 | 54.9 | 54.5 | 52.2 |
| Fiscal year | Aug 2022 | Aug 2023 | Aug 2024 | Aug 2025 | Aug 2026 |
|---|---|---|---|---|---|
| Cash & equivalents | 121 | 154 | 167 | 152 | 175 |
| Receivables | 107 | 97.6 | 104 | 106 | 113 |
| Inventory | 83.7 | 74.8 | 72.9 | 78.8 | 70.7 |
| Current assets | 342 | 356 | 372 | 376 | 407 |
| Net PP&E | 41.4 | 39.0 | 40.3 | 53.3 | 54.4 |
| Goodwill | 258 | 266 | 270 | 290 | 290 |
| Total assets | 757 | 763 | 777 | 828 | 859 |
| Payables | 72.5 | 50.5 | 43.4 | 42.9 | 42.8 |
| Deferred revenue | 2.8 | 2.9 | 2.3 | 3.4 | 4.9 |
| Current liabilities | 153 | 148 | 129 | 137 | 149 |
| Short-term debt | 0.0 | 3.8 | 5.0 | 7.5 | 10.0 |
| Long-term debt | 200 | 210 | 190 | 182 | 172 |
| Total liabilities | 439 | 436 | 385 | 394 | 406 |
| Shareholders' equity | 319 | 327 | 392 | 434 | 453 |
| Backlog (remaining obligations) | 2.8 | 2.9 | 2.3 | 3.4 | 4.9 |
| Fiscal year | Aug 2022 | Aug 2023 | Aug 2024 | Aug 2025 | Aug 2026 |
|---|---|---|---|---|---|
| Operating cash flow | 51.7 | 77.6 | 81.3 | 111 | 130 |
| Capital expenditure | 8.4 | 9.4 | 11.4 | 19.3 | 10.6 |
| Free cash flow | 43.3 | 68.2 | 69.9 | 92.0 | 120 |
| Depreciation & amortisation | 19.6 | 16.3 | 13.3 | 15.7 | 17.5 |
| Stock-based compensation | 13.6 | 8.6 | 10.9 | 13.0 | 12.1 |
| Acquisitions | 0.0 | 0.0 | 0.0 | 26.7 | 0.0 |
| Share buybacks | 75.1 | 57.7 | 38.3 | 68.7 | 81.1 |
| Dividends paid | 2.4 | 2.3 | 2.2 | 2.2 | 2.1 |
| Dividend per share | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Fiscal year | Aug 2022 | Aug 2023 | Aug 2024 | Aug 2025 | Aug 2026 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | 4.7% | −1.5% | 4.6% | 5.7% |
| Operating income growth (YoY) | – | 173.7% | 44.9% | 9.8% | −3.2% |
| EPS growth (YoY) | – | 215.4% | 90.2% | 9.0% | 1.2% |
| Gross margin | 46.5% | 49.3% | 51.1% | 50.5% | 49.2% |
| Operating margin | 5.4% | 14.0% | 20.6% | 21.6% | 19.8% |
| Net margin | 2.7% | 7.8% | 14.5% | 15.0% | 13.8% |
| Return on equityBlank when equity is negative | 4.9% | 14.3% | 21.9% | 21.4% | 19.8% |
| ROCEEBIT ÷ (assets − current liabilities) | 5.1% | 13.7% | 18.8% | 19.3% | 18.2% |
| Free cash flow margin | 7.6% | 11.4% | 11.9% | 14.9% | 18.3% |
| Cash conversion (CFO ÷ net income) | 3.30x | 1.67x | 0.95x | 1.20x | 1.45x |
| Receivable days | 68 | 60 | 65 | 63 | 63 |
| Inventory days | 100 | 90 | 92 | 94 | 78 |
| Payable days | 87 | 61 | 55 | 51 | 47 |
| Debt ÷ equity | 0.63x | 0.66x | 0.50x | 0.44x | 0.40x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | 79.3 | 59.7 | 27.4 | 38.1 | 7.6 |
| Current ratio | 2.24x | 2.40x | 2.88x | 2.74x | 2.73x |
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.